Table 1.
Sub no | FibroSure*
|
Sex | Age | Hispanic | Ethnicity | Biopsy
|
HCV RNA | ALT/AST | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Stage | Grade | Stage | Lobular Inflam | Portal Inflam | |||||||
1001 | 0.41 | 0.07 | F | 49 | Y | White | 3 | 1 | 1 | 5 719 786 | 14/29 |
1002 | 0.14 | 0.57 | M | 39 | Y | White | 2 | 2 | 2 | 5 457 293 | 97/51 |
1003 | 0.82 | 0.78 | M | 55 | Y | White | 4 | 1 | 1 | 5 455 572 | 90/92 |
1006 | 0.64 | 0.3 | F | 46 | N | White | 2 | 2 | 2 | 118 899 | 44/47 |
1007 | 0.7 | 0.83 | M | 53 | N | Black | 3 | 2 | 2 | 1 902 865 | 133/172 |
1008 | 0.5 | 0.26 | M | 51 | N | Black | 2–3 | 1 | 2 | 5 708 610 | ND/40 |
1009 | 0.3 | 0.09 | M | 55 | N | Black | 2 | 1–2 | 1–2 | 5 669 440 | 24/22 |
1010 | 0.53 | 0.37 | M | 51 | N | Black | 1 | 1 | 1 | 447 250 | 50/35 |
1011 | ND | ND | F | 43 | N | Black | 2 | 1 | 2 | 285 631 | 42/42 |
1014 | 0.19 | 0.18 | M | 57 | N | Black | 1 | 0 | 1 | 354 752 | 38/26 |
1015 | 0.49 | 0.68 | M | 48 | N | Black | 3 | 2 | 2 | 140 936 | 122/152 |
1018 | 0.47 | 0.57 | M | 63 | N | Black | 3 | 1 | 3 | 238 912 | 80/70 |
1020 | 0.68 | 0.6 | M | 56 | N | Black | 3–4 | 1 | 2 | 6 417 203 | 54/57 |
1021 | 0.54 | 0.41 | M | 60 | N | Black | 2 | 2 | 2 | 7 596 697 | 56/63 |
1022 | 0.61 | 0.28 | M | 51 | N | Black | 2–3 | 2 | 2 | 87 063 | 32/36 |
1026 | 0.28 | 0.46 | M | 47 | Y | White | 2 | 2 | 2 | 692 655 | 75/66 |
1027 | 0.57 | 0.61 | M | 53 | Y | White | 2 | 2 | 3 | 1 687 484 | 78/48 |
Sub no, subject number; M, male; F, female; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ND, not done.
Fibrosure measurements performed by Labcorp, Research Triangle Park, NC.